tiprankstipranks
Trending News
More News >
Opus Genetics, Inc. (IRD)
NASDAQ:IRD

Compare Opus Genetics (IRD) vs. Competitors

Compare
1,264 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Opus Genetics
$4.39
$312.34M
-25.22
281.74%
8 Buy
0 Hold
0 Sell
Strong Buy
Ovid Therapeutics
$2.62
$345.51M
-6.90
509.30%
7 Buy
0 Hold
0 Sell
Strong Buy
Shattuck Labs
$6.22
$445.13M
-7.52
436.21%
5 Buy
1 Hold
0 Sell
Strong Buy
Inhibikase Therapeutics
$1.80
$218.28M
-3.06
-25.62%
4 Buy
0 Hold
0 Sell
Strong Buy
Surrozen
$25.15
$215.57M
-0.39
113.37%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biomea Fusion
$1.14
$80.60M
-1.25
-58.84%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IRD
Opus Genetics
4.39
3.24
281.74%
OVID
Ovid Therapeutics
2.62
2.18
490.09%
STTK
Shattuck Labs
6.22
4.98
401.61%
IKT
Inhibikase Therapeutics
1.80
-0.57
-24.05%
SRZN
Surrozen
25.15
13.15
109.58%
BMEA
Biomea Fusion
1.14
-1.65
-59.14%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts